Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nasdaq Biotechnology Ishares ETF (NQ: IBB )

117.36 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, Jun 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 240
Open 117.36
Bid (Size) 116.78 (1)
Ask (Size) 117.80 (13)
Prev. Close 117.36
Today's Range 117.36 - 117.36
52wk Range 104.29 - 177.37
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Flu Shots Can Cut Down Risk Of Alzheimer's, Exploratory Study Finds
Alzheimer's is a tough neurological disease to tackle, given the difficulty in diagnosing at an early stage, and the limited and effective treatment options currently available. 
Via Benzinga

Performance

YTD
-22.98%
-22.98%
1 Month
+0.59%
+0.59%
3 Month
-11.57%
-11.57%
6 Month
-22.89%
-22.89%
1 Year
-28.16%
-28.16%

More News

Read More
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Via Benzinga
7 Biotech Stocks With Key Catalysts Coming in July
Via InvestorPlace
What’s Next For Biotech And Healthcare
Via Talk Markets
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
Via Benzinga
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Via Benzinga
Are We Heading Towards Recession?
Via Talk Markets
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
Via Benzinga
Demand Destruction as Seen in the Transportation Sector
Via Talk Markets
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
Via Benzinga
A Moment Of Truth - Ways To Help You Deal With A New Reality
Via Talk Markets
The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease
Via Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
Via Benzinga
Can the Fed Control Inflation with Higher Rates?
Via Talk Markets
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
Via Benzinga
For Signs of a Relief Rally, Watch the S&P 500 v. Retail
Via Talk Markets
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
Via Benzinga
Why This Biotech ETF May Be About to Break Out
Via Benzinga
Watch For The Nasdaq 100 and S&P 500 to Clear Their Mini Ranges
Via Talk Markets
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
Via Benzinga
Are Gold And Silver Ready for A Momentum Breakout?
Via Talk Markets
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
Via Benzinga
3 Things Need to Align for The Next Big Market Move
Via Talk Markets
Musk Stirs Up A Hornet's Nest In Epstein Case, Apple WWDC Expectations, Kim Jong-Un Goes Ballistic And More: 5 Key Stories You May Have Missed From This Weekend
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.